QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rebouche, C. J. Search for Related Content PubMed PubMed Citation Articles by Rebouche, C. J.

Effect of Dietary Carnitine Isomers and -Butyrobetaine on L-Carnitine Biosynthesis and Metabolism in the Rat^1,2,

Neuromuscular Research Laboratory and Department of Neurology, Mayo Foundation, Rochester, MN 55905

Oral supplementation with L-carnitine or DL-carnitine for treatment of primary and secondary carnitine deficiency syndromes is becoming increasingly popular, yet little is known about the systemic manifestations of oral intake of large doses of those compounds, particularly the D-isomer of carnitine. To determine the possible beneficial and/or toxic effects or oral carnitine isomers and the carnitine precursor, -butyrobetaine, in the rat, groups of male, weanling rats were fed a carnitine-free diet (control) supplemented with various amounts of L-carnitine, D-carnitine, DL-carnitine or -butyrobetaine for 32 days. Rats fed diets supplemented with L-carnitine (0.1–1.0%) had increased L-carnitine concentrations in serum and all tissues studied. Mean L-carnitine concentrations in serum and tissues (except liver) from rats fed equivalent amounts of L-carnitine, as the racemic mixture DL-carnitine, were greater than controls but were consistently lower than in rats fed L-carnitine alone. D-Carnitine (1% of diet) significantly reduced serum and heart L-carnitine concentrations from control levels, and the effects of -butyrobetaine depended on the level of dietary supplementation. Dietary L-carnitine, D-carnitine and -butyrobetaine (1%) reduced carnitine biosynthesis from -N-trimethyl-L-lysine in vivo. However, this decrease probably resulted from effects on transport of -butyrobetaine into tissues, rather than on the biosynthetic pathway per se. Other than mild diarrhea with high levels of some supplements, no toxic effects of these compounds were observed under the conditions employed and within the time frame of the study. However, the negative effects of high levels of dietary -butyrobetaine and D-carnitine on tissue L-carnitine concentrations observed in this study may presage more severe systemic alterations over a longer period of time.

KEY WORDS: • carnitine • carnitine biosynthesis • carnitine transport • -butyrobetaine

¹ This study was supported by U.S. Public Health Service National Institutes of Health Grant AM 27451 and by a Research Center Grant from the Muscular Dystrophy Association.

² This study was presented in part at the Fourth Triennial Joint Meeting of the American Institute of Nutrition, American Society for Clinical Nutrition and the Canadian Society for Nutritional Sciences, University Park, PA, July 22–24, 1982, Rebouche, C. J. (1982) Effect of dietary carnitine (CARN) isomers and -butyrobetaine (BB) on L-CARN biosynthesis and metabolism in the rat. J. Nutr. 112(6), xx.

Manuscript received 21 February 1983.

This article has been cited by other articles:

				J. LIU, E. HEAD, H. KURATSUNE, C. W. COTMAN, and B. N. AMES Comparison of the Effects of l-Carnitine and Acetyl-l-Carnitine on Carnitine Levels, Ambulatory Activity, and Oxidative Stress Biomarkers in the Brain of Old Rats Ann. N.Y. Acad. Sci., November 1, 2004; 1033(1): 117 - 131. [Abstract] [Full Text] [PDF]